12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Compass, PanGen Biotech Inc. deal

Compass (formerly Cyplasin Biomedical Ltd.) and PanGen signed a memorandum of understanding under which PanGen will produce active pharmaceutical ingredients (APIs) which will...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >